Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001819790-23-000073)

Filing Details

Accession Number:: 0001819790-23-000073
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-08-17 18:02:59
Reporting Period:: 2023-08-15

Accepted Time:: 2023-08-17 18:02:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1819790	Tarsus Pharmaceuticals Inc.	TARS	Biological Products, (No Disgnostic Substances) (2836)	814717861

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1842190	Yeu Elizabeth Lin	C/O Tarsus Pharmaceuticals, Inc. 15440 Laguna Canyon Road, Suite 160 Irvine CA 92618		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-08-15	9,506	$16.80	15,866	No	4	P	Indirect	By Spouse's Roth IRA

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Spouse's Roth IRA

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,040	Indirect	By 401(k) Plan
Common Stock	2,000	Direct